Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Aeglea BioTherapeutics In...

    NASDAQ: AGLE · Real-Time Price · USD
    12.01
    0.75 (6.66%)
    At close: Nov 27, 2023, 9:00 PM

    Aeglea BioTherapeutics Revenue

    Aeglea BioTherapeutics reported an annual revenue of $2.33M, reflecting a -87.57% growth. For the quarter ending September 30, 2023, Aeglea BioTherapeutics generated $0 in revenue.
    Revenue (ttm)
    $2.33M
    Revenue Growth
    -87.57%
    Price / Sales Ratio
    16.28
    Revenue / Employee
    $33.75K
    Employees
    69
    Market Cap
    48.63M

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist